Craft

ReNAgade Therapeutics

Total Funding

$300 M

ReNAgade Therapeutics Summary

Company Summary

Overview
ReNAgade Therapeutics is a company that focuses on developing gene therapy technology. It develops and produces ribonucleic acid (RNA) medicines. The company provides a platform for coding, editing, and gene insertion tools in an all-RNA system.
Type
Private
Status
Active
Founded
2021
Website
https://renagadetx.com/
Cybersecurity rating
Sectors

Table of Contents

Footer menu